Assure Holdings Corp., a provider of intraoperative neuromonitoring services, has announced a series of significant corporate developments. On April 8, 2024, the company's Board of Directors approved an amendment to increase the authorized shares of common stock from 9 million to 250 million, which was subsequently approved by stockholders on May 14, 2024. The Certificate of Amendment was filed with the State of Nevada on May 17, 2024, to effectuate the increase. Additionally, Assure has received a decision from the Nasdaq Hearings Panel granting an extension until July 22, 2024, to regain compliance with Nasdaq's listing requirements in relation to its upcoming transaction with Danam Health Inc. This news was released in a press statement on May 16, 2024. Furthermore, Assure has scheduled a webinar presentation for stockholders and investors, as announced in a press release on May 17, 2024. These announcements come in the context of a proposed transaction between Assure and Danam Health Inc., for which materials have been filed with the SEC, including a registration statement containing a prospectus and a proxy statement.

Assure Holdings Corp., a provider of intraoperative neuromonitoring services, has announced a series of significant corporate developments. On April 8, 2024, the company's Board of Directors approved an amendment to increase the authorized shares of common stock from 9 million to 250 million, which was subsequently approved by stockholders on May 14, 2024. The Certificate of Amendment was filed with the State of Nevada on May 17, 2024, to effectuate the increase. Additionally, Assure has received a decision from the Nasdaq Hearings Panel granting an extension until July 22, 2024, to regain compliance with Nasdaq's listing requirements in relation to its upcoming transaction with Danam Health Inc. This news was released in a press statement on May 16, 2024. Furthermore, Assure has scheduled a webinar presentation for stockholders and investors, as announced in a press release on May 17, 2024. These announcements come in the context of a proposed transaction between Assure and Danam Health Inc., for which materials have been filed with the SEC, including a registration statement containing a prospectus and a proxy statement.